Fortress Biotech
FBIO
#9463
Rank
S$0.15 B
Marketcap
S$4.58
Share price
0.57%
Change (1 day)
81.89%
Change (1 year)

Revenue for Fortress Biotech (FBIO)

Revenue in 2026 (TTM): S$84.84 Million

According to Fortress Biotech 's latest financial reports the company's current revenue (TTM ) is S$85.38 Million. In 2025 the company made a revenue of S$81.22 Million an increase over the revenue in the year 2024 that were of S$78.39 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fortress Biotech from 2011 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) S$84.84 M4.46%
2025 S$81.22 M3.61%
2024 S$78.39 M-29.76%
2023 S$0.11 B9.92%
2022 S$0.10 B9.18%
2021 S$92.99 M54.16%
2020 S$60.32 M22.16%
2019 S$49.38 M-126.16%
2018 -S$0.19 Billion-175.24%
2017 S$0.25 B951.9%
2016 S$23.85 M1853.86%
2015 S$1.22 M
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Veracyte
VCYT
S$0.69 B 718.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$0.24 B 191.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
S$0.14 M-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
S$0.42 B 399.56%๐Ÿ‡บ๐Ÿ‡ธ USA